Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures.
Charles A Herzog, Jennie Z Ma, Allan J Collins
https://pubmed.ncbi.nlm.nih.gov/15159290/Actively Recruiting
Led by Singapore General Hospital · Updated on 2026-04-29
50
Participants Needed
1
Research Sites
12 weeks
Total Duration
The PRECEDENCE study is a pilot feasibility trial investigating early targeted temperature management TTM using a wearable cooling vest in adults who have had an out-of-hospital cardiac arrest OHCA and achieved return of spontaneous circulation ROSC. The study aims to assess whether cooling can be safely and effectively started by emergency medical services EMS before hospital arrival. This research will help guide a larger trial to evaluate the clinical impact of early cooling on neurological recovery in these patients. Participants who meet criteria will be assigned to receive pre-hospital TTM using the CarbonCool4 cooling vest, which is designed for rapid application by paramedics immediately after ROSC and provides conductive surface cooling without interfering with care. The cooling vest is applied during transport and exchanged for a hospital vest upon arrival, followed by standard post-cardiac arrest treatment. The study compares this intervention with standard pre-hospital care and follows patients through hospital discharge. During the study, researchers will monitor feasibility through recruitment rates, treatment delivery, adherence to protocols, and acceptability among providers. They will also assess hospital TTM use, time to reach target temperature, neurological outcomes at discharge using CPC scores, and safety outcomes like overshoot cooling, bradyarrhythmias, and skin injury. The study duration is anticipated to be about one year, with outcomes tracked through hospital discharge and follow-up periods up to 30 days.
CONDITIONS
PRE-hospital Cooling to improvE carDiac arrEst Neurological outComEs (PRECEDENCE)
S
Shir Lynn Lim, MBBS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Singapore General Hospital
Lead Sponsor
Singapore Civil Defence Force
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From ROSC until hospital arrival, approximately up to 12 hours
Participants who achieve return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest will receive early targeted temperature management using the CarbonCool® cooling vest applied immediately in the pre-hospital setting and maintained during transport to the hospital.
Continuous cooling during transport with 1 immediate pre-hospital application and 1 vest exchange upon hospital arrival
Duration - Up to hospital discharge, average 30 days
Participants are followed through hospital discharge to assess neurological outcomes and safety endpoints related to cooling intervention.
Assessments during hospital stay up to discharge
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Charles A Herzog, Jennie Z Ma, Allan J Collins
https://pubmed.ncbi.nlm.nih.gov/15159290/Josef Dankiewicz, Tobias Cronberg, Gisela Lilja...
https://pubmed.ncbi.nlm.nih.gov/34133859/Sandra M Eldridge, Claire L Chan, Michael J Campbell...
https://pubmed.ncbi.nlm.nih.gov/27777223/Arezou Sayad, Mir Davood Omrani, Ghasem Solgi...
https://pubmed.ncbi.nlm.nih.gov/28865414/Niklas Nielsen, Jørn Wetterslev, Tobias Cronberg...
https://pubmed.ncbi.nlm.nih.gov/24237006/Comilla Sasson, Mary A M Rogers, Jason Dahl...
https://pubmed.ncbi.nlm.nih.gov/20123673/Pimjai Anthanont, Michael D Jensen
https://pubmed.ncbi.nlm.nih.gov/27581474/Singapore General Hospital
Lead Sponsor
Singapore Civil Defence Force
Collaborating Sponsor